SPECIFICITY OF DRUG PRICING IN THE KYRGYZ REPUBLIC
https://doi.org/338.532.4.025.24
Abstract
The state policy of pricing for medicines in the Kyrgyz Republic is crucial to ensure public access to pharmacotherapy. This affects the cost of medicines, making them more acceptable to those who need them.
Purpose of the work. To study the specificity of drug pricing in the Kyrgyz Republic.
Material and methods. The work uses data from the official websites of the healthcare systems and the Ministry of Justice of the Kyrgyz Republic, using methods: logical, analytical, statistical, content analysis, graphic.
Results. The paper presents the mechanisms and key factors of drug price formation in the Kyrgyz Republic, as well as the features of state control over compliance with pricing. A regressive scale of margins, marginal wholesale and retail prices depending on the base price per unit of goods is shown. A pricing procedure has been developed in the Kyrgyz Republic, which includes 6 stages. The positive and negative sides of drug pricing regulation have been identified. It is revealed that pricing in the Kyrgyz Republic is determined by multiple factors, including government regulation, market mechanisms, inflation, competition, social factors, customs duties and taxes, as well as currency fluctuations.
About the Authors
K. Zh. Satybaldiev
Кыргызская государственная медицинская академия им. И.К. Ахунбаева
Россия
Россия
G. Ya. Ibragimova
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Россия
Россия
E. A. Akhmetova
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Россия
Россия
References
1. WHO. A comprehensive and equitable solution to drug pricing [Elektronnyi resurs] URL: https://www.who.int/ru/newsroom/commentaries/detail/a-comprehensive-and-fair-solution-to-the-price-of-medicines https:// www.who.int/activities/ensuring-fairprices-for-medicines (data obrashcheniya: 23.10.2024) (in Russ)
2. Dzhienbekova Ch.M., Ismailov I.Z., Sabirova T.S. Preferential drug provision to the population of the Kyrgyz Republic within the framework of compulsory medical insurance. Modern problems of science and education. 2023;3.; [Elektronnyi resurs] URL: https file:///C:/Users/Пользователь/Downloads/28mt_2_2017_(28).pdf (data of access 23.02.2024) (in Russ).
3. WHO. Essential Medicines and Health Products Price and Availability Monitoring Mobile Application [Elektronnyi resurs] URL: https://www.who.int/teams/health-product-and-policy-standards/medicines-selection-ip-and-affordability/affordability-pricing/medmonmobile-monitoring (data of access 23.10.2024). (in Russ)
4. Musina N.Z. [et al.] Analysis of pricing schemes and price regulation of the cost of drugs in foreign countries. Medical Technologies Assessment and Choice. 2017; 2(28):30-39. [Elektronnyi resurs] URL: file:/C:/Users/ Downloads/28mt_2_2017_(28).pdf. (data of access 23.10.2024). (in Russ)
5. Open Working Group proposal for Sustainable Development Goals. Sustainable Development Knowledge Platform. United Nations. [Elektronnyi resurs] URL: https://sustainabledevelopment.un.org/sdgsproposal (data of access 23.10.2024). (in Russ)
6. Poryadok registratsii tsen na lekarstvennye sredstva v Kyrgyzskoi Respublike (s izmeneniyami soglasno Postanovleniyu Kabineta ministrov ot 20 maya 2022g.№268) (The procedure for registration of prices for medicines in the Kyrgyz Republic (as amended by Resolution of the Cabinet of Ministers dated May 20, 2022 No. 268)) Prakticheskoe rukovodstvo.-MZ KR. Bishkek, 2021:25. (data of access 23.10.24) (in Russ).
7. Rovbel R.L. Analyzing the Problems and Opportunities of Reference Pricing for the Use by State Government and Local Self-Government Bodies in Procurement Activities and Housing Development. Management Sciences. 2018;8(2):44-51. [Elektronnyi resurs] URL: https://managementscience.fa.ru/jour/article/view/148/152 (data of access 1.11.2024). (in Russ)
8. Goals to Transform Our World [Электронный ресурс] URL:https://www.un.org/sustainabledevelopment/blog/2015/08/transformingdata obrashcheniya our-world-document-adoption/( data of access 23.10.24) (in Russ)
Review
For citations:
Satybaldiev K.Zh., Ibragimova G.Ya., Akhmetova E.A. SPECIFICITY OF DRUG PRICING IN THE KYRGYZ REPUBLIC. Bashkortostan Medical Journal. 2024;19(6):66-71. (In Russ.) https://doi.org/338.532.4.025.24
Views:
71
JATS XML
Email this article 
